Prescriptions made by Hoa P Nguyen

Data for 2018

886

Medicare Part D Prescriptions Filled, Including Refills

Rank: 312 out of 897 providers in this state and specialty

$1.8M

Total Retail Price of All Prescriptions

Rank: 295 out of 897 providers in this state and specialty

145

Patients Receiving at Least One Drug in Part D

Rank: 170 out of 897 providers in this state and specialty

63%

Patients 65 Years and Older

70

Average Age of Patients

Average age of patients for providers in this state and specialty is 72

Drug Categories

O

Opioid

An opioid drug. Prescription opioids (painkillers) can help alleviate certain kinds of pain in the short term but carry serious health risks.
A

Antibiotic

Used to treat bacterial infections but are often prescribed incorrectly to treat viral infections, such as chest colds or the flu.
P

Antipsychotic

Used to manage psychosis, principally in schizophrenia but also in a range of other psychotic disorders.

Prescription Data

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume. Rank in State ranks all providers that have the self-identified specialty of Hematology-Oncology in California and ranks the number of prescriptions that have been made for the specific drug.

Drug Name Rank in State Total Prescriptions Filled with Refills Prescript. to 65+ Patients Receiving this Drug Patients 65+ OAP
1 ANASTROZOLE1260
of 6280
1200 prescriptions
Less than 1% of all prescriptions
1030310 patients
21% of all patients
< 11
2 TAMOXIFEN CITRATE830
of 4320
390 prescriptions
Less than 1% of all prescriptions
280110 patients
8% of all patients
< 11
3 HYDROXYUREA670
of 5410
400 prescriptions
Less than 1% of all prescriptions
400< 11< 11
4 LETROZOLE1410
of 5050
230 prescriptions
Less than 1% of all prescriptions
< 11< 11
5 IBRANCE
(PALBOCICLIB)
290
of 3180
350 prescriptions
Less than 1% of all prescriptions
350< 11< 11
6 METHADONE HCL40
of 320
330 prescriptions
Less than 1% of all prescriptions
110< 11< 11O
7 CELECOXIB60
of 270
250 prescriptions
Less than 1% of all prescriptions
< 11< 11
8 GABAPENTIN660
of 3830
120 prescriptions
Less than 1% of all prescriptions
< 11< 11
9 PREDNISONE650
of 5640
370 prescriptions
Less than 1% of all prescriptions
150 patients
10% of all patients
< 11
10 XARELTO
(RIVAROXABAN)
660
of 3350
130 prescriptions
Less than 1% of all prescriptions
< 11< 11
11 IMBRUVICA
(IBRUTINIB)
530
of 3100
250 prescriptions
Less than 1% of all prescriptions
130< 11< 11
12 SPRYCEL
(DASATINIB)
110
of 960
190 prescriptions
Less than 1% of all prescriptions
< 11< 11
13 SERTRALINE HCL190
of 480
160 prescriptions
Less than 1% of all prescriptions
160< 11< 11
14 REVLIMID
(LENALIDOMIDE)
850
of 4340
190 prescriptions
Less than 1% of all prescriptions
190< 11< 11
15 HYDROMORPHONE HCL130
of 940
260 prescriptions
Less than 1% of all prescriptions
< 11< 11O
16 DEXAMETHASONE720
of 5630
350 prescriptions
Less than 1% of all prescriptions
200220 patients
15% of all patients
< 11
17 ZYTIGA
(ABIRATERONE ACETATE)
570
of 2600
140 prescriptions
Less than 1% of all prescriptions
140< 11< 11
18 ONDANSETRON HCL680
of 5380
330 prescriptions
Less than 1% of all prescriptions
210150 patients
10% of all patients
< 11
19 HYDROCODONE-ACETAMINOPHEN
(HYDROCODONE/ACETAMINOPHEN)
800
of 4890
290 prescriptions
Less than 1% of all prescriptions
140120 patients
8% of all patients
< 11O
20 XTANDI
(ENZALUTAMIDE)
530
of 2300
120 prescriptions
Less than 1% of all prescriptions
00< 1100 patients
Less than 1% of all patients
21 MORPHINE SULFATE ER
(MORPHINE SULFATE)
400
of 1920
110 prescriptions
Less than 1% of all prescriptions
00< 1100 patients
Less than 1% of all patients
O
22 PROCHLORPERAZINE MALEATE510
of 3950
390 prescriptions
Less than 1% of all prescriptions
230210 patients
14% of all patients
< 11
23 OLANZAPINE50
of 180
240 prescriptions
Less than 1% of all prescriptions
< 11< 11P
24 LORAZEPAM680
of 3810
110 prescriptions
Less than 1% of all prescriptions
< 11< 11
25 CEPHALEXIN80
of 260
140 prescriptions
Less than 1% of all prescriptions
130 patients
9% of all patients
< 11A